Science Explorer Back to mapMap
Discussion
Topic · Rheumatology

Musculoskeletal synovial abnormalities and treatments

Musculoskeletal synovial abnormalities and treatments is a research topic within Rheumatology. Science Explorer counts 19k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis and treatment of synovial disorders, including synovial chondromatosis, pigmented villonodular synovitis, and tenosynovial giant cell tumor. It covers various aspects such as imaging, surgical treatment, radiotherapy, arthroscopic management, bursitis, molecular pathways, and ultrasound evaluation.

  • Synovial Chondromatosis
  • Pigmented Villonodular Synovitis
  • Tenosynovial Giant Cell Tumor
  • Imaging
  • Surgical Treatment
  • Radiotherapy
  • Arthroscopic Management
  • Bursitis
  • Molecular Pathways
  • Ultrasound Evaluation
Research works
19k
fractional, since 1950
In the world top 10%
1.9k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+6%
the tick is no change
Largest producer
United States
31% of the 10 largest, 2022-now
Musculoskeletal synovial abnormalities and treatments

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Musculoskeletal synovial abnormalities and treatments research?

By volume, the United States and India publish the most (679 and 378 works in 2022-now).

By volume, 2022-now

  1. 1 United States 679 works
  2. 2 India 378 works
  3. 3 China 336 works
  4. 4 Japan 157 works
  5. 5 United Kingdom 142 works
  6. 6 Türkiye 124 works
  7. 7 Germany 107 works
  8. 8 Italy 106 works
  9. 9 France 90 works
  10. 10 South Korea 88 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 30.8%India: 17.1%China: 15.2%Japan: 7.1%6 others listed: 29.8%31%largest
United States679 · 30.8%India378 · 17.1%China336 · 15.2%Japan157 · 7.1%6 others listed657 · 29.8%

Shares of the rows listed above, not of the whole node.

Which institutions lead Musculoskeletal synovial abnormalities and treatments research?

By volume in 2022-now, All India Institute of Medical Sciences publishes the most Musculoskeletal synovial abnormalities and treatments research, followed by Harvard University and Peking University.

Who are the leading researchers in Musculoskeletal synovial abnormalities and treatments?

The most-cited researchers publishing on Musculoskeletal synovial abnormalities and treatments include Cyrus Cooper, Jun Wang and Gregory Y.H. Lip.

  1. 1 Cyrus Cooper United Kingdom 342k citations
  2. 2 Jun Wang China 340k citations
  3. 3 Gregory Y.H. Lip United Kingdom 311k citations
  4. 4 Jasvinder A. Singh United States 247k citations
  5. 5 Marc Ladanyi United States 217k citations
  6. 6 David John Hunter Australia 211k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Musculoskeletal synovial abnormalities and treatments?

The most cited paper in Musculoskeletal synovial abnormalities and treatments is "The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis" (Frank C. Arnett, Steven M. Edworthy, Daniel A. Bloch et al., 1988), with 19,994 citations. Next come "Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee" (6,848) and "Osteoarthritis cartilage histopathology: grading and staging" (2,405).

Most cited papers
#PaperReleasedCitations
1 The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis Frank C. Arnett, Steven M. Edworthy, Daniel A. Bloch et al. · Arthritis & Rheumatism Mar 1988 19,994
2 Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee Roy Davis Altman et al. · Arthritis & Rheumatism Aug 1986 6,848
3 Osteoarthritis cartilage histopathology: grading and staging Kenneth P. H. Pritzker, Steffen Gay, Sergio A. Rodríguez Jiménez et al. · Osteoarthritis and Cartilage Open access 20 Oct 2005 2,405
4 The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria Javad Parvizi, Timothy L. Tan, Karan Goswami et al. · The Journal of Arthroplasty 26 Feb 2018 2,166
5 Hip morphology influences the pattern of damage to the acetabular cartilage Martín Beck, Morteza Kalhor, Michael Leunig et al. · Journal of Bone and Joint Surgery - British Volume Open access 22 Jun 2005 1,998
All 99 most cited papers, with filters and sorting

Where is Musculoskeletal synovial abnormalities and treatments research done?

The largest centres of Musculoskeletal synovial abnormalities and treatments research in 2022-now are Beijing (China), New York (United States), Seoul (South Korea) and New Delhi (India).

Largest cities, 2022-now

  1. 1 BeijingChina 53 works
  2. 2 New YorkUnited States 48 works
  3. 3 SeoulSouth Korea 39 works
  4. 4 New DelhiIndia 39 works
  5. 5 LondonUnited Kingdom 36 works
  6. 6 IstanbulTürkiye 35 works
  7. 7 TokyoJapan 35 works
  8. 8 BostonUnited States 31 works
  9. 9 ShanghaiChina 30 works
  10. 10 ChennaiIndia 26 works
See Musculoskeletal synovial abnormalities and treatments on the map

Where is the best place to study Musculoskeletal synovial abnormalities and treatments?

Among universities, judged by research, Harvard University, Leiden University and All India Institute of Medical Sciences score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 15.08%fractional works in this field (log) →share of work in the world top 10% →Leiden UniversityHarvard UniversityPeking UniversityAll India Institute …
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 72.415.3%3.7×33 +25.4%
2Leiden UniversityNetherlands 55.024.8%5.4×8 -31.3%
3All India Institute of Medical SciencesIndia 52.91.8%11.4×35 +21.7%
4Peking UniversityChina 51.512.8%4.6×26 -10.3%
5New York UniversityUnited States 50.915.3%4.4×14 +54.8%
6Sichuan UniversityChina 48.222.7%2.2×14 +55.4%
7Shanghai Jiao Tong UniversityChina 41.614.8%2.0×16 +42.2%
8Stanford UniversityUnited States 41.115.2%2.2×9 +32.9%
9University College LondonUnited Kingdom 36.614.6%2.3×10 -10.9%
10Capital Medical UniversityChina 28.213.5%2.8×8 +152.0%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Musculoskeletal synovial abnormalities and treatments, country by country

Is Musculoskeletal synovial abnormalities and treatments research growing?

Output in 2022-2025 was 6% higher than in 2018-2021, peaking in 2021. The fastest-growing topics are Musculoskeletal synovial abnormalities and treatments.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Musculoskeletal synovial abnormalities and treatments as a percentage of every work published that year, 0.014% in 2024.

still counting0.010%0.020%0.030%Musculoskeletal synovial abnormalities and treatments0.013% in 202519801990200020102020

Fractional works of Musculoskeletal synovial abnormalities and treatments over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Musculoskeletal synovial abnormalities and treatments10.5% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Musculoskeletal synovial abnormalities and treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.